Transcatheter closure of patent ductus arteriosus using duct occluder: an eleven-year experience from a single tertiary cardiac center

Achyut Sarkar; Neha Rani; Prashant Kumar; Shyam Sundar Chaudhary; Suman Chatterjee

doi:10.18203/2320-6012.ijrms20193141

Authors

Achyut Sarkar Department of cardiology, The Institute of Post-Graduate Medical Education and Research, Kolkata, West Bengal, India
Neha Rani Department of Dermatology, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India
Prashant Kumar Department of cardiology, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India
Shyam Sundar Chaudhary Department of Dermatology, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India
Suman Chatterjee Department of cardiology, The Institute of Post-Graduate Medical Education and Research, Kolkata, West Bengal, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20193141

Keywords:

Background, Patent Ductus Arteriosus (PDA) is a common congenital disorder. As an isolated lesion, PDA constitutes 6 to 11% of all congenital heart disease. PDA needs closure to eliminate pulmonary over circulation leading to volume overload of left ventr

Abstract

Background: Patent Ductus Arteriosus (PDA) is a common congenital disorder. As an isolated lesion, PDA constitutes 6 to 11% of all congenital heart disease. PDA needs closure to eliminate pulmonary over circulation leading to volume overload of left ventricle, pulmonary vascular obstructed disease.

Methods: This retrospective study was carried out in pediatric cardiology unit of Institute of Postgraduate Medical Education and Research, Kolkata from September 2005 to August 2016, which included 503 patients.

Results: Device closure was attempted in 492 patient’s Procedural success was achieved in 85% cases on table, in who check aortogram revealed complete closure of PDA. In 15% cases, residual shunt was present. In 12% of cases, residual shunt disappeared during follow-up echocardiogram over 6-month follow-up. In 3% cases, small shunt remained at 6-month and 1-year follow up.

Conclusion: Transcatheter closure of PDA by duct occluder is safe and effective with good mid-term outcome. The optimum assessment of ductul size and anatomy is crucial for optimum device size, which prevents residual shunt, device embolization and protrusion.

Metrics

Metrics Loading ...

References

Chessa M, Mohamed B, Giusti S, Butera G, Bini RM, Carano N, et al. Transcatheter treatment of patent ductus arteriosus. Ital Heart J. 2002;3:1092-7.

Aldo Castanedo. A congenital heart disease: a surgical-historical perspective. Ann Thorac Surg. 2005;78(6):S 2217-20.

Gross RE, Hubbard JP. Surgical ligation of patent ductus arteriosus: A report of first successful case. J Am Med Assoc. 1939;112:729-31.

Fan LI, Cambell DN, Clarke DR, Washington RL, Fix EJ, White CW, et al. Paralyzed left vocal cord associated with ligation of patent ductus arteriosus. J Thoracic Cardiovasc Surg. 1989;98:611-3.

Soreneson KE, Kristensen B, Hansen OK. Frequency of occurrence of residual ductal flow after surgical ligation by color-flow mapping. Am J Cardiol. 1991;76:653-4.

Postmann W, Wierry L, Warnke H. Closure of PDA without thoracotomy. Ger Med Mon. 1967;12:259-61.

Rashkind WJ, Mullins CE, Hellenbrand WE. Non-surgical closure of PDA: Clinical application of Rashkind PDA occluder system. Circulation. 1987;75:583-92.

Rao PS, Sideris EB, Haddad J, Rey C, Hausdorf G, Wilson AD, et al. Transcatheter occlusion of patent ductus arteriosus with adjustable buttoned device. Initial clinical experience. Circulation. 1993 Sep;88(3):1119-26.

Cambier PA, Kirby WC, Wortham DC, Moore JW. Percutaneous closure of small (<2.5 mm) patent ductus arteriosus using coil embolization. Am J Cardiol. 1992;69:815-6.

Masura J, Walsh KP, Thaopoulous B, Chan C, Bass J, Goussous Y, et al. Catheter closure of moderate –large size patent ductus arteriosus using the new Amplatzer duct occluder: Immediate and short term results. J Am Coll Cardiol. 1998;31:878-82.

Hoyer MH. Novel use of the Amplatzer plug for closure of a patent ductus arteriosus. Catheter Cardiovasc Interv. 2005;65:577-80.

Masura J, Tittel P, Gavora P, Podnar T. Long-term outcome of transcatheter patent ductus arteriosus closure using Amplatzer duct occluders. American heart J. 2006 Mar 1;151(3):755-e7.

Pass RH, Hijazi Z, Hsu DT, Lewis V, Hellenbrand WE. Multicenter USA Amplatzer patent ductus arteriosus occlusion device trial: initial and one-year results. J Am Coll Cardiol. 2004;44:513-9.

Hansmann G, Apitz C. Treatment of Children with Pulmonary Hypertension. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European paediatric pulmonary vascular disease network, endorsed by ISHLT and DGPK. Heart 2016;102:ii67-85.

Mavroudis C, Backer CL, Gevitz M. Forty-six years of patent ductus arteriosus division at Children’s Memorial Hospital of Chicago. Standards for comparison. Ann Surg. 1994;220:402-10.

Masura J, Walsh KP, Thanopoulous B, Chan C, Bass J, Goussous Y, et al. Catheter closure of moderate- to large-sized patent ductus arteriosus using the new Amplatzer duct occluder: immediate and short-term results. J Am Coll Cardiol. 1998;31(4):878-82.

Latson LA, McManus BM, Doer C, Kilzer K, Cheatham JP. Endocarditis risk of the USCI PDA umbrella for transcatheter closure of patent ductus arteriosus. Circulation. 1994;90(5):2525-8.

Brunetti MA, Ringel R, Owada C, Coulson J, Jennings JM, Hoyer MH, et al. Percutaneous closure of patent ductus arteriosus: a multiinstitutional registry comparing multiple devices. Catheter Cardiovasc Interv. 2010;76:696-702.

Parra-Bravo JR, Cruz-Ramírez A, Toxqui-Terán A, Juan- Martínez E, Chávez-Fernández AA, Lazo-Cárdenas C, et al. Transcatheter closure of patent ductus arteriosus using the Amplatzer duct occluder in children: initial and one-year results. Arch Cardiol Mex. 2009;79:114-20.

Sultan M, Ullah M, Sadiq N, Akhtar K, Akbar H. Transcatheter device closure of patent ductus arteriosus. J Coll Physicians Surg Pak. 2014;24(10):710-3.

Ali SH and Abdalla SES. Percutaneous closure of patent ductus arteriosus: initial experience of Sohag University. Egyptian Heart J. 2014;66:143-7.

Viswnathan S and Kumar RK. Assessment of operability of congenital cardiac shunts with increased pulmonary vascular resistance. Catheterization and Cardiovascular Interventions. 2008;71:665-70.

Wang JK, Wu MH, Hwang JJ, Chiang FT, Lin MT, Lue HC. Transcatheter closure of moderate to large patent ductus arteriosus with the Amplatzer duct occluder. Catheter Cardiovasc Interv. 2007;69(4):572-8.

Đukić M, Parezanović V, Đorđević SA, Stefanović I, Miranović V, Ilić S, et al. Transcatheter closure of patent ductus arteriosus using Flipper coil and Amplatzer duct occluder: a ten-year experience from a single center. Srp Arh Celok Lek. 2017;145(11-12):564-70.

Ghasemi A, Pandya S, Reddy SV, Turner DR, Du W, Navabi MA, et al. Trans-catheter closure of patent ductus arteriosus-What Is the Best Device? Catheter Cardiovasc Interv. 2010;76(5):687-95